IRIS - Res&Arch Institutional Research Information System - Research & Archive

GAETANI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.265
EU - Europa 669
AS - Asia 497
SA - Sud America 6
AF - Africa 5
OC - Oceania 5
Totale 2.447
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.263
IE - Irlanda 219
SG - Singapore 219
IT - Italia 172
HK - Hong Kong 152
CN - Cina 94
SE - Svezia 60
FI - Finlandia 37
DE - Germania 29
UA - Ucraina 22
RU - Federazione Russa 21
RO - Romania 18
CZ - Repubblica Ceca 17
BE - Belgio 16
FR - Francia 14
NL - Olanda 14
GB - Regno Unito 9
KR - Corea 9
GR - Grecia 6
JP - Giappone 5
NZ - Nuova Zelanda 5
VN - Vietnam 5
AT - Austria 4
BR - Brasile 4
EG - Egitto 4
IN - India 3
CH - Svizzera 2
CO - Colombia 2
IR - Iran 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
CA - Canada 1
CR - Costa Rica 1
DK - Danimarca 1
ES - Italia 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.447
Salva come PNG Salva come JPEG
Città #
Chandler 257
Dublin 219
Singapore 179
Hong Kong 147
Boardman 123
Santa Clara 75
San Mateo 68
Perugia 62
Altamura 59
Des Moines 42
Medford 40
Princeton 40
Andover 39
Lawrence 39
Ann Arbor 38
Wilmington 35
Ashburn 34
Beijing 26
Helsinki 24
Redmond 24
Los Angeles 20
Redwood City 18
Brussels 13
Falls Church 13
Brno 12
Munich 11
Timisoara 10
Houston 9
Seoul 9
Amsterdam 8
Fairfield 7
Rome 7
Bucharest 6
Dallas 6
Lappeenranta 6
Norwalk 6
Saint Petersburg 6
Seattle 6
Auckland 5
Dong Ket 5
Milan 5
Tokyo 5
Woodbridge 5
Chicago 4
Giza 3
Groningen 3
Guangzhou 3
Moscow 3
Olomouc 3
Shenzhen 3
Wielsbeke 3
Bogotá 2
Brixen 2
Cambridge 2
Foligno 2
Jacksonville 2
New York 2
Newark 2
San Paolo di Civitate 2
Turin 2
Vienna 2
Alviano 1
Anshan 1
Athens 1
Atlanta 1
Baltimore 1
Bollebygd 1
Bratislava 1
Brookfield 1
Böblingen 1
Changchun 1
Chiajna 1
Chiaravalle 1
Curitiba 1
Dearborn 1
Elk Grove Village 1
Florence 1
Frankfurt am Main 1
Fremont 1
Harbin 1
Hefei 1
Hengshui 1
Hsinchu 1
Islamabad 1
Izmir 1
Kaifeng 1
Kolkata 1
Lausanne 1
Lisbon 1
Ma'anshan 1
Madrid 1
Mogi Guacu 1
Monselice 1
Montreuil 1
Mumbai 1
Nanjing 1
Napoli 1
Nuremberg 1
Paris 1
Parma 1
Totale 1.852
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 119
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 95
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 82
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 74
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 69
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 64
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 61
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 59
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 59
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 58
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 56
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 55
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 55
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 51
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 50
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 48
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 48
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 47
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 45
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 44
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 42
Serum neurofilament light chain as a preclinical marker of neurodegeneration 42
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 42
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 42
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 41
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 40
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 40
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 39
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 39
Infliximab monotherapy for neuro-Behçet's disease: a case report 38
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 38
A blood test for Alzheimer's disease: a step forward 37
Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms 37
Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use 36
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 35
Neurofilament light chain as a biomarker in neurological disorders 35
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 35
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 35
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 34
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 34
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 33
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 32
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 31
Blood biomarkers may distinguish among dementia disorders 29
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 28
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 27
Impact of post-contrast MRI in the definition of active multiple sclerosis 26
Clinical correlates of state and trait anxiety in multiple sclerosis 25
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 25
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 21
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 21
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 19
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 18
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 17
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 17
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 17
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 16
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 16
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 16
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 16
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 16
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 14
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 14
Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases 13
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 12
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study 11
SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis 10
Intrathecal B cell activation and memory impairment in multiple sclerosis 9
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 8
Hippocampal neuroplasticity and inflammation: Relevance for multiple sclerosis 8
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 6
Fluid biomarkers in multiple sclerosis: from current to future applications 4
Research advancement in fluid biomarkers for Parkinson's disease 3
Totale 2.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 0 0 0 0 2 2 15 7 22 21 38
2020/2021159 3 4 4 1 74 17 7 20 11 5 6 7
2021/2022380 3 49 12 12 26 10 5 93 17 46 61 46
2022/2023858 45 184 15 68 62 104 4 38 302 1 26 9
2023/2024511 24 54 15 11 7 2 97 20 68 26 80 107
2024/2025483 13 108 69 75 122 96 0 0 0 0 0 0
Totale 2.578